Cargando…
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367900/ https://www.ncbi.nlm.nih.gov/pubmed/28356758 http://dx.doi.org/10.2147/OTT.S135456 |
Ejemplares similares
-
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma
por: Xu, Jianping, et al.
Publicado: (2016) -
Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases
por: Xu, Jian‐ping, et al.
Publicado: (2016) -
An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
por: Zhang, Ying, et al.
Publicado: (2015) -
A meta-analysis for the efficacy and safety of icotinib combined with radiotherapy in treating brain metastases of non-small cell lung cancer
por: Zhang, Bo
Publicado: (2023) -
Corrigendum: Analysis of platelet parameters and activation markers in hematologic metastases of lung cancer
Publicado: (2019)